title: Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response.
abstract: BACKGROUND
  Inadequate extracellular conditions can adversely affect the environment of the ER and impinge on the maturation of nascent proteins. The resultant accumulation of unfolded proteins activates a signal transduction pathway, known as the unfolded protein response, which serves primarily to protect the cell during stress and helps restore homeostasis to the ER.
  
  
  RESULTS
  Microarray analysis of the unfolded protein response in a human medulloblastoma cell line treated with thapsigargin revealed that, in addition to known targets, a large number of proangiogenic factors were up-regulated. Real-Time PCR analyses confirmed that four of these factors, VEGFA, FGF2, angiogenin and IL8, were transcriptionally up-regulated in multiple cell lines by various ER stress inducers. Our studies on VEGFA regulation revealed that XBP-1(S), a UPR-inducible transcription factor, bound to two regions on the VEGFA promoter, and analysis of XBP-1 null mouse embryonic fibroblasts revealed that it contributes to VEGFA expression in response to ER stress. ATF4, another UPR-inducible transcription factor, also binds to the VEGFA gene, although its contribution to VEGFA transcription appeared to be fairly modest. We also found that VEGFA mRNA stability is increased in response to UPR activation, via activation of AMP kinase, demonstrating that increased mRNA levels occur at two regulatory points. In keeping with the mRNA levels, we found that VEGFA protein is secreted at levels as high as or higher than that achieved in response to hypoxia.
  
  
  CONCLUSIONS
  Our results indicate that the UPR plays a significant role in inducing positive regulators of angiogenesis. It also regulates VEGFA expression at transcriptional, post-transcriptional and post-translational levels and is likely to have widespread implications for promoting angiogenesis in response to normal physiological cues as well as in pathological conditions like cancer.
authors.affiliation: Department of Genetics & Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
authors.forename: Ethel R
authors.initials: ER
authors.lastname: Pereira
authors.forename: Nan
authors.initials: N
authors.lastname: Liao
authors.forename: Geoff A
authors.initials: GA
authors.lastname: Neale
authors.forename: Linda M
authors.initials: LM
authors.lastname: Hendershot
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D004721:Endoplasmic Reticulum / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016209:Interleukin-8 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D018919:Neovascularization, Physiologic; D011401:Promoter Regions, Genetic; D011499:Protein Processing, Post-Translational; D051381:Rats; D012259:Ribonuclease, Pancreatic / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D056811:Unfolded Protein Response; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism
chemical_list: D043925:Angiogenesis Inducing Agents; C508606:CXCL8 protein, human; D016209:Interleukin-8; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2; C046366:angiogenin; D012259:Ribonuclease, Pancreatic
references.citation: J Biol Chem. 2005 Mar 18;280(11):9963-72
references.pmid: 15640157
references.citation: Am J Pathol. 1998 Jun;152(6):1445-52
references.pmid: 9626049
references.citation: Biochem J. 2006 Jan 1;393(Pt 1):201-9
references.pmid: 16124869
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16657-62
references.pmid: 19805353
references.citation: J Biol Chem. 1995 Aug 25;270(34):19761-6
references.pmid: 7544346
references.citation: J Mol Biol. 2002 May 17;318(5):1351-65
references.pmid: 12083523
references.citation: Mol Cell Biol. 2009 Aug;29(15):4295-307
references.pmid: 19470760
references.citation: Mol Cell. 2001 Jun;7(6):1165-76
references.pmid: 11430820
references.citation: J Neuropathol Exp Neurol. 1985 Sep;44(5):472-85
references.pmid: 2993532
references.citation: Nat Immunol. 2003 Apr;4(4):321-9
references.pmid: 12612580
references.citation: J Biol Chem. 2009 Mar 6;284(10):6038-42
references.pmid: 19112107
references.citation: Circ Res. 2007 Feb 16;100(3):328-41
references.pmid: 17307971
references.citation: Transl Oncol. 2009 Mar;2(1):31-8
references.pmid: 19252749
references.citation: Science. 2000 Jan 28;287(5453):664-6
references.pmid: 10650002
references.citation: Cancer Res. 2004 Sep 1;64(17):5943-7
references.pmid: 15342372
references.citation: Mol Cell. 2000 Dec;6(6):1355-64
references.pmid: 11163209
references.citation: Genes Dev. 2000 Jan 15;14(2):152-7
references.pmid: 10652269
references.citation: J Immunol. 2007 Sep 1;179(5):2969-78
references.pmid: 17709512
references.citation: Cell. 1996 Aug 9;86(3):353-64
references.pmid: 8756718
references.citation: Cell. 2004 Apr 30;117(3):387-98
references.pmid: 15109498
references.citation: J Biol Chem. 2000 Aug 25;275(34):26484-91
references.pmid: 10849421
references.citation: Cancer Res. 2001 May 15;61(10):4206-13
references.pmid: 11358846
references.citation: Mol Cell Biol. 2003 Nov;23(21):7448-59
references.pmid: 14559994
references.citation: J Biol Chem. 2003 Sep 12;278(37):34864-73
references.pmid: 12840028
references.citation: Immunity. 2004 Jul;21(1):81-93
references.pmid: 15345222
references.citation: Nucleic Acids Res. 1989 Aug 11;17(15):6419
references.pmid: 2771659
references.citation: J Biol Chem. 2004 Apr 9;279(15):14844-52
references.pmid: 14747470
references.citation: Mol Cell Biol. 2003 Aug;23(16):5651-63
references.pmid: 12897138
references.citation: Acta Haematol. 2001;106(4):148-56
references.pmid: 11815711
references.citation: Cell. 2001 Dec 28;107(7):881-91
references.pmid: 11779464
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12625-30
references.pmid: 11035797
references.citation: Nat Rev Cancer. 2004 Dec;4(12):966-77
references.pmid: 15573118
references.citation: J Clin Invest. 2001 Jul;108(1):41-50
references.pmid: 11435456
references.citation: Mol Cell. 2000 Nov;6(5):1099-108
references.pmid: 11106749
references.citation: PLoS One. 2010 Mar 08;5(3):e9575
references.pmid: 20221394
references.citation: Mol Pharmacol. 2005 Oct;68(4):1061-73
references.pmid: 15998873
references.citation: Endocr Rev. 1997 Feb;18(1):4-25
references.pmid: 9034784
references.citation: Nature. 2005 Dec 15;438(7070):932-6
references.pmid: 16355210
references.citation: Clin Exp Immunol. 2006 May;144(2):179-87
references.pmid: 16634789
references.citation: J Biol Chem. 1996 Feb 2;271(5):2746-53
references.pmid: 8576250
references.citation: Mol Cell Biol. 1995 Oct;15(10):5363-8
references.pmid: 7565686
references.citation: Endocr Rev. 2004 Aug;25(4):581-611
references.pmid: 15294883
references.citation: Cancer Res. 2007 Jul 15;67(14):6700-7
references.pmid: 17638880
references.citation: Mol Cell Biol. 2002 Jun;22(11):3864-74
references.pmid: 11997520
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: Curr Top Dev Biol. 2006;76:217-57
references.pmid: 17118268
references.citation: J Clin Invest. 2005 Feb;115(2):268-81
references.pmid: 15690081
references.citation: Nat Rev Cancer. 2008 Nov;8(11):880-7
references.pmid: 18923433
references.citation: Biochem Soc Trans. 2003 Feb;31(Pt 1):162-8
references.pmid: 12546677
references.citation: Mol Biol Cell. 1999 Nov;10(11):3787-99
references.pmid: 10564271
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Cancer Res. 1997 Mar 1;57(5):963-9
references.pmid: 9041202
references.citation: Cancer Res. 2008 Jan 1;68(1):152-61
references.pmid: 18172307
references.citation: Cell Tissue Res. 2002 Dec;310(3):257-70
references.pmid: 12457224
references.citation: Nature. 2001 Jul 19;412(6844):300-7
references.pmid: 11460154
references.citation: Clin Cancer Res. 2000 May;6(5):1900-8
references.pmid: 10815914
references.citation: J Biol Chem. 2005 May 27;280(21):20331-9
references.pmid: 15788408
references.citation: Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
references.pmid: 17565364
references.citation: Nat Rev Cancer. 2008 Sep;8(9):705-13
references.pmid: 19143055
references.citation: Eur J Cancer. 2008 Dec;44(18):2760-5
references.pmid: 19026532
references.citation: Blood. 2008 Jul 15;112(2):330-9
references.pmid: 18451308
references.citation: Genes Dev. 1998 Jun 15;12(12):1812-24
references.pmid: 9637683
references.citation: Mol Biol Cell. 1995 Mar;6(3):283-96
references.pmid: 7612964
references.citation: Nat Med. 2003 Jun;9(6):653-60
references.pmid: 12778163